INDO US BIO-TECH | BOMBAY SUPER HYBRID SEEDS | INDO US BIO-TECH/ BOMBAY SUPER HYBRID SEEDS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 108.6 | 38.9% | View Chart |
P/BV | x | 8.6 | 40.5 | 21.4% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH BOMBAY SUPER HYBRID SEEDS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
BOMBAY SUPER HYBRID SEEDS Mar-23 |
INDO US BIO-TECH/ BOMBAY SUPER HYBRID SEEDS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 187 | 67.2% | |
Low | Rs | 25 | 37 | 67.6% | |
Sales per share (Unadj.) | Rs | 61.6 | 217.3 | 28.3% | |
Earnings per share (Unadj.) | Rs | 7.2 | 16.0 | 45.1% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 17.3 | 46.5% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 53.7 | 101.2% | |
Shares outstanding (eoy) | m | 10.03 | 10.49 | 95.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 0.5 | 237.3% | |
Avg P/E ratio | x | 10.4 | 7.0 | 149.0% | |
P/CF ratio (eoy) | x | 9.4 | 6.5 | 144.5% | |
Price / Book Value ratio | x | 1.4 | 2.1 | 66.5% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 754 | 1,173 | 64.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 31 | 41.4% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 2,279 | 27.1% | |
Other income | Rs m | 0 | 7 | 3.1% | |
Total revenues | Rs m | 618 | 2,286 | 27.0% | |
Gross profit | Rs m | 94 | 215 | 43.6% | |
Depreciation | Rs m | 8 | 13 | 61.4% | |
Interest | Rs m | 12 | 30 | 39.6% | |
Profit before tax | Rs m | 74 | 178 | 41.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 11 | 13.9% | |
Profit after tax | Rs m | 72 | 168 | 43.1% | |
Gross profit margin | % | 15.2 | 9.4 | 161.1% | |
Effective tax rate | % | 2.0 | 5.9 | 33.6% | |
Net profit margin | % | 11.7 | 7.4 | 159.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 1,248 | 48.0% | |
Current liabilities | Rs m | 123 | 753 | 16.3% | |
Net working cap to sales | % | 77.1 | 21.7 | 354.7% | |
Current ratio | x | 4.9 | 1.7 | 293.9% | |
Inventory Days | Days | 1 | 0 | 798.8% | |
Debtors Days | Days | 146,261,410 | 13,747,173 | 1,063.9% | |
Net fixed assets | Rs m | 90 | 87 | 102.6% | |
Share capital | Rs m | 100 | 105 | 95.5% | |
"Free" reserves | Rs m | 445 | 458 | 97.0% | |
Net worth | Rs m | 545 | 563 | 96.7% | |
Long term debt | Rs m | 17 | 7 | 247.8% | |
Total assets | Rs m | 689 | 1,335 | 51.6% | |
Interest coverage | x | 7.2 | 6.9 | 104.0% | |
Debt to equity ratio | x | 0 | 0 | 256.2% | |
Sales to assets ratio | x | 0.9 | 1.7 | 52.5% | |
Return on assets | % | 12.3 | 14.8 | 82.6% | |
Return on equity | % | 13.3 | 29.8 | 44.6% | |
Return on capital | % | 15.3 | 36.6 | 41.8% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0.6 | 0.0% | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | 13 | 0.0% | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 13 | 0.0% | |
Net fx | Rs m | 0 | -13 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | -80 | -6.5% | |
From Investments | Rs m | -67 | -26 | 259.7% | |
From Financial Activity | Rs m | 63 | 104 | 60.3% | |
Net Cashflow | Rs m | 1 | -2 | -77.5% |
Indian Promoters | % | 70.2 | 73.9 | 95.0% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 26.2 | 114.1% | |
Shareholders | 1,166 | 16,437 | 7.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | BOMBAY SUPER HYBRID SEEDS |
---|---|---|
1-Day | 8.77% | -1.34% |
1-Month | 26.17% | 6.39% |
1-Year | 113.64% | -4.00% |
3-Year CAGR | 152.58% | 154.71% |
5-Year CAGR | 42.16% | 87.57% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the BOMBAY SUPER HYBRID SEEDS share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of BOMBAY SUPER HYBRID SEEDS the stake stands at 73.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of BOMBAY SUPER HYBRID SEEDS.
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
BOMBAY SUPER HYBRID SEEDS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of BOMBAY SUPER HYBRID SEEDS.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.